Atropos Presents at Ci4CC 2023: The Clinical and Fiscal ROI of Evidence-Based Practice

 

Atropos CEO Brigham Hyde presented Leveraging RWD to Drive Clinical ROI: Year 1 ROI Study of the Atropos Health Informatics Consult at the Cancer Informatics for Cancer Centers meeting in San Diego on February 22, 2023.

The presentation covers progress along the 40+ year journey toward the learning health system. It’s been a long road from Feinstein’s “Estimating Prognosis with the Aid of a Conversational-Mode Computer Program” to where we are today.

This is the right moment for clinical data to make its way to actionable insights for patient care. The technology is finally available, and the benefits are clear. Atropos ROI studies show what we’ve long expected - that evidence-based practice yields results consistent with the triple aim.

Insights from clinical data should be accessible to doctors, credible enough for safe and effective use, and personalized so they are relevant for each patient. Learn how Atropos is making this a reality at scale: https://www.atroposhealth.com/healthcare-organizations

Or contact us directly at info@atroposhealth.com

Previous
Previous

Wall Street Journal: Generative AI Makes Headway in Healthcare

Next
Next

Associations of Tinnitus Incidence with Use of Tumor Necrosis Factor-Alpha Inhibitors among Patients with Autoimmune Conditions